Neoplasms, Kidney Terminated Phase 1 Trials for Varlilumab (DB11930)

Also known as: Kidney Neoplasms / Kidney Neoplasm

IndicationStatusPhase
DBCOND0032585 (Neoplasms, Kidney)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02386111A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaTreatment
NCT02543645A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerTreatment